Obstrüktif Uyku Apnesi Sendromu ve Kardiyovasküler Sonuçları
Özet
Obstrüktif uyku apnesi sendromu (OUAS), uyku sırasında üst hava yolunun tıkanmasıyla karakterize, önemli morbidite ve mortaliteye yol açan ciddi bir solunum bozukluğudur. OUAS esnasında meydana gelen aralıklı hipoksemi, hiperkapni, otonomik sistem değişiklikleri ve sempatik aktivite artışı gibi patofizyolojik mekanizmalar; endotel disfonksiyonu, oksidatif stres ve inflamasyonu tetiklemektedir. Bu süreçler; sistemik hipertansiyon, koroner arter hastalığı, sol kalp yetmezliği, pulmoner hipertansiyon, kardiyak aritmiler, serebrovasküler hastalıklar ve uykuda ani ölüm gibi çok ciddi kardiyovasküler sonuçlara zemin hazırlamaktadır. Araştırmalar, özellikle dirençli hipertansiyon ve miyokard infarktüsü geçiren hastalarda OUAS prevalansının son derece yüksek olduğunu ortaya koymaktadır. Erken tanı konulması ve sürekli pozitif hava yolu basıncı (CPAP) gibi etkin tıbbi tedavilerin uygulanması, uykudaki solunum problemlerini düzeltmenin yanı sıra kardiyovasküler komplikasyonların gerilemesinde, sol ventrikül hipertrofisinin azalmasında ve uzun vadeli mortalite riskinin düşürülmesinde hayati bir rol oynamaktadır.
Obstructive sleep apnea syndrome (OSAS) is a severe respiratory disorder characterized by upper airway obstruction during sleep, leading to significant morbidity and mortality. Pathophysiological mechanisms during OSAS, such as intermittent hypoxemia, hypercapnia, autonomic alterations, and increased sympathetic activity, trigger endothelial dysfunction, oxidative stress, and inflammation. These processes predispose patients to serious cardiovascular consequences, including systemic hypertension, coronary artery disease, left heart failure, pulmonary hypertension, cardiac arrhythmias, cerebrovascular disease, and sudden cardiac death during sleep. Research highlights an extremely high prevalence of OSAS, particularly among patients with resistant hypertension and myocardial infarction. Early diagnosis and the implementation of effective medical treatments, such as continuous positive airway pressure (CPAP), play a vital role not only in correcting sleep-related breathing sleep disturbances but also in reversing cardiovascular complications, reducing left ventricular hypertrophy, and lowering long-term mortality risks.
Referanslar
Redline S, Kump K, Tishler PV, Browner I, Ferrette V. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Crit Care Med 1994;149:722–6.
Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 2003; 41:1429-1437.
Dursunoglu D, Dursunoglu N. Cardiovascular diseases in obstructive sleep apnea. Tuberk Toraks 2006; 54: 382-96.
Dursunoğlu D. Uyku apne ve kardiyovasküler hastalıklar: Fizyopatoloji, komplikasyonlar tanı ve tedavide pratik yaklaşımlar. Özlem Matbaacılık, İstanbul 2009.
He J, Kryger MH, Zorick FJ. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 1988; 94:9-14
Koskenvuo M, Kaprio J, Heikkilä K, Sarna S, Telakivi T, Partinen M. Snoring as a risk factor for ischaemic heart disease and stroke in men. Br Med J 1987; 294:1619.
Virolainen J, Ventila M, Turto H, KupariM. Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol 1995;79:455–60.
Sajkov D, Cowie RJ, Thornton AT, Espinoza HA, McEvoy RD. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1994;149:416–22.
Köktürk O.Obstrüktif Uyku Apne Sendromu Sonuçları. Tüberküloz ve Toraks 2000;48 :273-289.
Hung J, Whitford EG, Parsons RW. Assosiation of sleep apnea with myocardial infarction in men. Lancet 1990; 336:261-264.
Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365:1046-53.
Hahn PY, Olson LJ, Somers VK Cardiovascular complications of obstructive sleep apnea. In: Lee-Chiong ed. Sleep: A Comprehensive Handbook. New Jersey 2006; 267-73.
Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993; 328: 303-7.
Roux F,D'Ambrosio C, Mohsenin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med 2000, 108:396-40.
M. Butt et al. Obstructive sleep apnea and cardiovascular disease, International Journal of Cardiology 139 (2010) 7–16.
Guilleminault C, Connaly S, Winkle R, Melvin K, Tilkian K. Cyclic variation of heart rate in sleep apne sydrome. Lancet 1984; 1:126-131.
Podszus T, Mayer J, Penzel T, Peter JH, Von Wichert P. Nocturnal hemodynamics in patients with obstructive sleep apnea. Eur J Respir Dis. 1986; 69:435-442.
Scharf SM. Influence of sleep state and breathing on cardiovascular function. In: Saunders NA, Sullivan CE, eds. Sleep and Breathing. Newyork, Marcel Decker, 1994; pp:221-23.
Tolle FA, Judy WV, Yu PL, Markand ON. Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Phsiol 1983; 55:1718-1724.
Friedman O, Logan AG. The price of obstructive sleep apnea-hypopnea: hypertension and other ill effects. Am J Hypertens 2009; 22:474.
Seif F, Patel SR, Walia H, et al. Association between obstructive sleep apnea severity and endothelial dysfunction in an increased background of cardiovascular burden. J Sleep Res 2013; 22:443.
Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897–904.
Hedner J, Darbo B, Ejnell H, Carlson J, Caidal K. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 1995; 8:222-229.
Naruse K, Naruse M, Honda T, Obana K, Sakurai H, Demeru H, Hirosawa K, Inagami I, Shizume K.. Atrial natriüretic peptide corralates with pulmonary arterial presssure and cardiak out put. Peptides 1987; 8(2):285-290.
Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG.. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103:1763-1768.
Çiftçi B. Obstrüktif Uyku Apne Sendromunun Sonuçları. Uykuda Solunum Bozuk-lukları Toraks Derneği Okulu Merkezi Kurslar 2005, Ankara.
Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOSexpression and bioactivity in human aortic endothelial cells.Circulation 2002;106:1439–41.
Valgimigli M, Merli E, Malagutti P, et al. Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress.Arch Biochem Biophys 2003;420:255–61.
Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure. Possible involvement of nitric oxide and asymmetric NG,NG Dimethylarginine. Circ J 2005;69:221–6.
Dursunoğlu N, Dursunoğlu D. Obstrüktif uyku apne sendromu, endotel disfonksiyonu ve koroner ateroskleroz. Tüberküloz ve Toraks Dergisi 2005; 53(3): 299-306.
Lavie P, Ben Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984; 108: 373-6.
Hoffmann M, Bybee K, Accurso V, Somers VK. Sleep apnea and hypertension. Minerva Med 2004;95(4):281-90.
Gonçalves SC, Martinez D, Gus M, et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 2007; 132:1858.
Walia HK, Li H, Rueschman M, et al. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. J Clin Sleep Med 2014; 10:835.
Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004;79(8):1036-46.
Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hyper- tension associated with resistant hypertension. Hypertension 2011; 58: 811-7.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, JonesDW, Materson BJ, Oparil S; Wright Jr JT; Roccella EJ. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003; 289:2560-2572.
Dhillon S, Chung SA, Fargher T, Hutere N, Shapiro CM. Sleep apnea, hypertension and the effects of continuous positive airway pressure. Am J Hypertens 2005; 18:594-6.
Baguet JP, Narkiewicz K, Mallion JM. Update on hypertension management: Obstructive sleep apnea and hypertension. J Hypertens 2006; 24:205-210.
Bayram, Nihal Akar, et al. "Relationship between the severity of obstructive sleep apnea and hypertension . The Anatolian Journal of Cardiology vol. 7, no. 4, 2007, p. 378+.
Nieto FJ, Young TB, Lind Bk, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study.JAMA 2000;283:1829-36.
Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359:204.
Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007; 50:417.
Andreas S, Schulz R, Werner GS, Kreuzer H. Prevalance of obstructive sleep apnea in patients with coronary artery disease. Coron Artery Dis 1996;7:541-5.
Ferguson KA, Fleetham JA. Consequences of sleep disordered breathing. Thorax 1998; 50:998-1004.
Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, Okada S, Ohta S, Naito H, Adachi M. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172:625-630.
Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi- Filho G. Early signs of atherosklerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172:613-618.
Konecny T, Kuniyoshi FH, Orban M, et al., “Underdiagnosis of sleep apnea in patients after acute myocardial infarction,” Journal of the American College of Cardio- logy 2010; 56: 742-3.
Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006;28(3):596-602.
Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, Bende M. An independent association beetween obstructive sleep apnoea and coronary artery diseaese. Eur Respir J 1999; 14:179-184.
Peker Y, Redline S. Update in sleep medicine 2013. Am J Respir Crit Care Med. 2014; 189: 1345-50.)
Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnea and nocturnal angine. Lancet 1995; 345:1085-1087.
Sanner B, Sturm A, Konermann M. Coranary heart in patients with OSA. Dtsch Med Wochenschr 1996; 121(30), Abst.:931-935.
Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 2007; 176:1274.
McNicholas WT, Bonsigore MR; Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-78.
Arias MA, Garcia F, Fernandez AA, et al. Obstructive Sleep Apnea Syndrome Affects Left Ventricular Diastolic Function.Eur Respir J 2002;20:1239-124.
Ursavaş A, Ege E. Obstructive sleep apnea and cardiovascular diseases. Anadolu Kardiyol Derg 2003;3:150-5.
Z. A. Atılgan ve ark. Obstrüktif uyku apne sendromu ve kardiyovasküler sorunlar Dicle Tıp Derg / Dicle Med J Cilt / Vol 38, No 2, 264-267.
Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010; 122:352.
Cloward TV, Walker JM, Farney RJ, Anderson JL. Left ventricular hypertrophy is a common Echocardiograghic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003; 124:594- 601.
Mansfield D, Naughton MT. Obstructive sleep apnoea, congestive heart failure and cardiovascular disease. Heart Lung Circ 2005:14:2-7.
Dursunoglu N, Dursunoglu D. Obstructive sleep apnea syndrome, endothelial dysfunction and coronary atherosclerosis. Tuberk Toraks 2005; 53: 299-306.
Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160: 1101-6.
Findley LJ, Zwillich CW, Ancoli-Israel S, et al. Cheyne-Stokes breathing during sleep in patients with left ventricular heart fail- ure. South Med J 1985; 78: 11-5.
Javaheri S, Parker TJ, Wexler L, et al. Occult sleep disordered breathing in stable congestive heart failure. Ann Intern Med 1995; 122: 487-92.
Guilleminault C, Connoly S, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52: 490-4.
Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne- Stokes respiration. Circulation 2000;102:61-6.
Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, et al. Cardiovascular effects of continous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233-41.
Bady E, Achkar A, Pascal S, et al. Pulmonary arterial hypertension in patients with sleep apnea syndrome. Thorax 2000;55:934-9.
Sanner BM, Doberauer C, Konermann M, et al. Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med 1997; 157:2483.
Chaouat A, Weitzenblum E, Krieger J, et al. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996; 109:380.
Atwood CW, Mc Crory D, Garcia JGN, et al. Pulmonary artery Hypertension and sleep disordered breathing. Chest 2004; 126:72-77.
Minai OA, Ricaurte B, Kaw R, et al. Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am J Cardiol 2009; 104:1300.
Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis 2009; 51:363.
Arias MA, García-Río F, Alonso-Fernández A, et al. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 2006; 27:1106.
Sanner BM, Konermann M, Sturm A, Müller HJ, Zidek W. Right ventricular dysfunction in patients with obstructive sleep apnoea sydrome. Eur Respir J 1997; 10:2079-2083.
Dursunoğlu N, Dursunoğlu D, Kılıç M. Impact of obstructive sleep apnea on right ventricular gloal function: sleep apnea and myocardial performance index. Respiration 2005; 72:278-284.
Nahmias J, Lao R, Karetzky M. Right ventricular dysfunction in obstructive sleep apnea: reversal with nasal continuous positive airway pressure. Eur Respir J 1996, 9: 945-51.
Simantrakis EN, Schiza IS, Marketou ME, Chrysostomakis SI, Chlouverakis GI, Klapsinos NC, Siafakas NS, Vardas PE. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: A long- term evaluation using an insertable loop recorder Eur Heart J 2004; 25:1070-1076.
Hoffstein V, Mateika S. Cardiac arrhythmias, snoring and sleep apnea. Chest 1994;106:466-471.
Gami AS, Friedman PA, Chung MK, et al. Therapy Insight: interactions between atrial fibrillation and obstructive sleep apnea. Nat Clin Pract Cardiovasc Med 2005; 2:145,75-77.
Porthan KM, Melin JH, Kupila JT, et al. Prevalence of sleep apnea syndrome in lone atrial fibrillation: a case-control study. Chest 2004; 125:879.
Braga B, Poyares D, Cintra F, et al. Sleep-disordered breathing and chronic atrial fibrillation. Sleep Med 2009; 10:212.
Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107:2589.
Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62:300.
Neilan TG, Farhad H, Dodson JA, et al. Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc 2013; 2:e000421.
Becker H, Brandenburg U, Peter JH, von Wichert P. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med 1995; 151:215-8.
Harbison J, O’Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal con tinuous positive airway pressure therapy. Chest 2000; 118: 591-5.
Simantirakis EN, Schiza SI, Marketou ME, et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J 2004; 25:1070.
Becker H, Brandenburg U, Conradt R, et al. [Influence of nCPAP therapy on bradycardic arrhythmias in sleep apnea]. Pneumologie 1993; 47 Suppl 4:706.
Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352:1206-14.
Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005; 127:2076.
Gami AS, Olson EJ, Shen WK, et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 2013; 62:610.
Fusco G, Macina F, Macarini L, Garribba AP, Ettorre GC. Magnetic resonance imaging in simple snoring and obstructive sleep apnea-hypopnea syndrome. Radiol Med 2004; 108: 238-54.
Mohsenin V, Valor R. Sleep apnea in patients with hemispheric stroke. Arch Phys Med Rehabil 1995;76:71-6.
Munoz R, Duran-Cantolla J, Martínez-Vila E, Gallego J, Rubio R, Aizpuru F, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006;37(9):2317-21.
Mohsenin V. Sleep-related breathing disorders and risk of stroke. Stroke 2001;32(6):1271-8.
Yaggi H, Mohsenin V. Sleep apnea and cerebrovascular dısease. In: Lee-Chiong ed. Sleep: A Comprehensive Handbook. New Jersey 2006;287-92.
